Patients who underwent partial pancreatic head resection or total pancreatectomy
Conditions
Interventions
Group 1: Endoscopic balloon dilatation (eBD) of the pylorus or gastrojejunostomy following partial or total pancreatectomy min. after postoperative day 5 in patients with persistent delayed gastric em
Sponsors
Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistraße 52, 20246 Hamburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who underwent open or minimally-invasive partial pancreatectomy or total pancreatectomy using a gastrojejunostomy or duodenojejunostomy for treatment of benign or malignant diseases of the pancreas.
Exclusion criteria
Exclusion criteria: - contraindication for endoscopic intervention - malcompliance - unable to sign informed consent or understand the details of the trial (e.g. language barrier)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean secretion of the nasogastric tube (NGT) during the two days after trial intervention compared with the mean NGT secretion during 3 days before intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Date of final NGT removal (postoperative day) - Mean duration of NGT placement after endoscopy - Start of oral enteral nutrition (post interventional day) - Number and duration of endoscopic interventions - Duration of intermediate or intensive care unit stay (days) - Morbidity (in-house) according to CDC classification. - Rate of postoperative pancreatic fistula (POPF, ISGPF definition) - Proportion of pylorus-preserving resections in relation to all resections - Conservative (medical) treatment strategies used for DGE therapy | — |
Countries
Germany
Contacts
Public ContactThilo Welsch
Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistraße 52, 20246 Hamburg
Outcome results
None listed